There have been 44 initial public offerings (IPOs) listed on the US stock markets in 2024 thus far, many of which continue to trade at a premium to their initial offering price, demonstrating the strength and buoyancy of...more
4/16/2024
/ Acquisitions ,
Capital Markets ,
Disclosure Requirements ,
Dual Track Process ,
Initial Public Offering (IPO) ,
Interest Rates ,
Life Sciences ,
Mergers ,
Price Inflation ,
Private Equity ,
Securities and Exchange Commission (SEC) ,
Shareholders ,
Stock Prices ,
Valuation ,
Wages
THE EUROPEAN COMMISSION PUBLISHES FINAL IMPLEMENTING REGULATION ON PROCEEDINGS PURSUANT TO THE FOREIGN SUBSIDIES REGULATION -
On July 10, 2023, the European Commission (the “Commission”) published its final regulation for...more
11/22/2023
/ Acquisitions ,
Capital Markets ,
Competition ,
Corporate Governance ,
Corruption ,
Court of Justice of the European Union (CJEU) ,
Cross-Border ,
EU ,
European Commission ,
European Merger Control Regulation ,
Foreign Subsidies ,
Merger Controls ,
Mergers ,
Regulatory Reform
Please join McDermott for our highly anticipated Life Sciences Dealmaking Symposium! Now in its 12th year, the Symposium offers a unique platform for education, insight sharing, purposeful networking and strategic...more
10/23/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Valuations ,
Capital Markets ,
Capital Raising ,
Carve Out Provisions ,
Collaboration ,
Cross-Border Transactions ,
Events ,
Health Care Providers ,
Health Technology ,
Initial Public Offering (IPO) ,
Investors ,
IP License ,
IP Portfolio ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity Firms ,
Publicly-Traded Companies ,
Special Purpose Acquisition Companies (SPACs)